Comparison of the incidence of acute kidney injury during treatment with vancomycin in combination with piperacillin–tazobactam or with meropenem
The purpose of this study was to evaluate the observed incidence of acute kidney injury (AKI) in adult patients receiving either piperacillin–tazobactam (PT) and vancomycin or meropenem and vancomycin for at least 48 h. In this retrospective cohort study, we included adult patients with no known ren...
Main Author: | Majed S. Al Yami |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-11-01
|
Series: | Journal of Infection and Public Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034117300199 |
Similar Items
-
Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital
by: Mohammed Al Nuhait, et al.
Published: (2018-01-01) -
ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH VANCOMYCIN AND PIPERACILLIN-TAZOBACTAM: A RETROSPECTIVE COHORT ANALYSIS
by: Rutter, Wilbur Cliff
Published: (2016) -
The potential of meropenem and piperacillin-tazobactam combination to Acinetobacter spp clinical isolates in vitro
by: Alindya Diani, et al.
Published: (2020-02-01) -
Acute kidney injury associated with concomitant use of vancomycin with piperacillin-tazobactam: a focused review and meta-analysis
by: Hatice Duygu Bas, et al.
Published: (2016-06-01) -
Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs
by: Katie E. Barber, et al.
Published: (2016-11-01)